Literature DB >> 8536373

Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant-induced arthritis.

A S Williams1, J P Camilleri, N Amos, B D Williams.   

Abstract

In this study we evaluated the comparative efficacy of free and liposomally conjugated methotrexate on both disease induction and suppression of acute inflammation in rat adjuvant-induced arthritis. Rats were given either empty liposomes (E-LIPO), free methotrexate (MTX) or the liposomally conjugated methotrexate (MTX-LIPO) at a dose of 100 micrograms/day for 7 consecutive days by the intravenous route. When MTX treatment was initiated on the day of arthritis induction the drug suppressed but did not abolish the development of joint inflammation. Free MTX had no significant anti-inflammatory effect upon an established arthritis when dosing was commenced on day 11 post-adjuvant induction. Conversely, MTX-LIPO did not affect the progression of the arthritis when dosing was started on day 0, but exerted a significant anti-inflammatory effect on an established arthritis. MTX-LIPO treatment was significantly less haematotoxic than free MTX.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8536373      PMCID: PMC1553368          DOI: 10.1111/j.1365-2249.1995.tb03853.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  Antiproliferative effects of methotrexate on peripheral blood mononuclear cells.

Authors:  N J Olsen; L M Murray
Journal:  Arthritis Rheum       Date:  1989-04

2.  Methotrexate inhibits macrophage activation as well as vascular and cellular inflammatory events in rat adjuvant induced arthritis.

Authors:  W J Johnson; M J DiMartino; P C Meunier; K A Muirhead; N Hanna
Journal:  J Rheumatol       Date:  1988       Impact factor: 4.666

3.  Efficient clodronate entrapment within multilamellar and unilamellar liposomes.

Authors:  W G Love; J P Camilleri; B D Williams
Journal:  J Pharmacol Toxicol Methods       Date:  1992-05       Impact factor: 1.950

4.  Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.

Authors:  R O Williams; M Feldmann; R N Maini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

5.  The cellular basis of adjuvant arthritis. II. Characterization of the cells mediating passive transfer.

Authors:  J D Taurog; G P Sandberg; M L Mahowald
Journal:  Cell Immunol       Date:  1983-08       Impact factor: 4.868

6.  Demonstration of novel anti-arthritic and anti-inflammatory effects of diphosphonates.

Authors:  C J Dunn; L A Galinet; H Wu; R A Nugent; S T Schlachter; N D Staite; D G Aspar; G A Elliott; N A Essani; N A Rohloff
Journal:  J Pharmacol Exp Ther       Date:  1993-09       Impact factor: 4.030

7.  Studies in the rat of antibody-sensitized and N-ethylmaleimide-treated erythrocyte clearance by the liver: effects of immune complex infusion and complement activation.

Authors:  N Yousaf; J C Howard; B D Williams
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

8.  Comparative efficacy and toxicity of 10-ethyl-10-deazaaminopterin and methotrexate in a mycobacterial rat arthritis model.

Authors:  K J Skeith; C Ramos-Remus; A S Russell
Journal:  J Rheumatol       Date:  1994-03       Impact factor: 4.666

9.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin.

Authors:  H L Currey; M Ziff
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

View more
  6 in total

1.  Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis.

Authors:  A S Williams; S G Jones; R M Goodfellow; N Amos; B D Williams
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

2.  [The future of methotrexate therapy and other folate inhibitors].

Authors:  C Fiehn
Journal:  Z Rheumatol       Date:  2011-02       Impact factor: 1.372

3.  Stealth Nanogels of Histinylated Poly Ethyleneimine for Sustained Delivery of Methotrexate in Collagen-Induced Arthritis Model.

Authors:  SamiraSadat Abolmaali; AliMohammad Tamaddon; Eskandar Kamali-Sarvestani; MohammadJavad Ashraf; Rasoul Dinarvand
Journal:  Pharm Res       Date:  2015-05-12       Impact factor: 4.200

Review 4.  Application of liposomes in treatment of rheumatoid arthritis: quo vadis.

Authors:  Bhupinder Kapoor; Sachin Kumar Singh; Monica Gulati; Reena Gupta; Yogyata Vaidya
Journal:  ScientificWorldJournal       Date:  2014-02-04

Review 5.  Rheumatiod Arthritis: An Updated Overview of Latest Therapy and Drug Delivery.

Authors:  Disha Kesharwani; Rishi Paliwal; Trilochan Satapathy; Swarnali Das Paul
Journal:  J Pharmacopuncture       Date:  2019-12-31

Review 6.  Liposomal Nanosystems in Rheumatoid Arthritis.

Authors:  Margarida Ferreira-Silva; Catarina Faria-Silva; Pedro Viana Baptista; Eduarda Fernandes; Alexandra Ramos Fernandes; Maria Luísa Corvo
Journal:  Pharmaceutics       Date:  2021-03-27       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.